Charles E. Triano Joins Pfizer as Head of Investor Relations

NEW YORK--(Business Wire)--
Pfizer Inc today announced that Charles E. Triano will join the
company as Senior Vice President, Investor Relations, effective June
23. Mr. Triano, who will be responsible for all investor relations
functions, including communicating the financial and operational
performance of the company with institutional and retail investors,
will report directly to Chief Financial Officer Frank D'Amelio.

Since 2000, Triano served as the Vice President of Investor
Relations at Forest Laboratories, where he initiated the company's
first formal investor relations and corporate communications program.
During his tenure, Forest's Investor Relations program was twice
ranked among the top three programs in the entire healthcare sector by
Institutional Investor Magazine, based on a survey of institutional
portfolio managers and analysts.

"We are pleased to welcome Chuck to Pfizer," said Mr. D'Amelio.
"As a seasoned investor relations executive who has earned the trust
of the investment community and built a highly respected investor
relations program, Chuck will be a clear asset to our company. In
addition, he brings a deep knowledge of the pharmaceutical industry
and its regulatory environment combined with extensive investor
relations experience, which will continue to strengthen our
relationship with the investment community and our shareholders."

Prior to joining Forest Laboratories, Triano served as Director of
Investor Relations at Bristol-Myers Squibb Company and as Managing
Director at The Carson Group (acquired by Thomson Financial in 2000),
the shareholder intelligence and investor relations consulting firm.

"I am delighted to join Pfizer, a global leader with a long and
storied history of bringing medical innovation to patients and
physicians," Mr. Triano said. "I am eager to begin sharing with
investors and shareholders Pfizer's strategy of accelerating the
pipeline and capturing new opportunities for global growth."

About Pfizer Inc

Founded in 1849, Pfizer is the world's largest research-based
pharmaceutical company. Pfizer is taking new approaches to advancing
better health as it discovers, develops, manufactures and delivers
quality, safe and effective prescription medicines to treat and help
prevent disease for both people and animals. Pfizer also partners with
healthcare providers, governments and local communities around the
world to expand access to medicines and to provide better quality
health care and health system support. At Pfizer, approximately 85,000
colleagues in more than 90 countries work every day to help people
stay happier and healthier longer and to reduce the human and economic
burden of disease worldwide.

Pfizer Inc
Media:
Shreya Jani, 212-733-4889
or
Investor:
Suzanne Harnett, 212-733-8009

Copyright Business Wire 2008